Rapid method for isolating extracellular nucleic acids
AssigneeQiagen GmbH
InventorsMartin Horlitz, Annette Nocon, Markus Sprenger-Haussels, Peter Grünefeld, Christoph Erbacher
Life of this patent
Estimating the term…
Loading patent…
AssigneeQiagen GmbH
InventorsMartin Horlitz, Annette Nocon, Markus Sprenger-Haussels, Peter Grünefeld, Christoph Erbacher
Estimating the term…
The present invention pertains to a method for isolating extracellular nucleic acids from a sample, wherein said sample is optionally stabilized, by binding the extracellular nucleic acids to a solid phase which carries anion exchange groups, comprising the following steps: binding the extracellular nucleic acids to the solid phase in a binding mixture having a first pH which allows binding the extracellular nucleic acids to the anion exchange groups of the solid phase; wherein the sample makes up at least 85% of the volume of the binding mixture; separating the solid phase with the bound extracellular nucleic acids; optionally washing the extracellular nucleic acids; optionally eluting extracellular nucleic acids from the solid phase. The method has the advantage that large sample volumes can be processed and that extracellular nucleic acids can be isolated rapidly with a high yield. The method is particularly suitable for automatable processes.
A method for isolating extracellular nucleic acids from a sample by binding the extracellular nucleic acids to a solid phase which carries anion exchange groups, comprising the following steps:
The method according to one or more of claims 1 to 10, in particular claims 1 and 9, wherein step a) has one or more of the following characteristics:
A method for isolating extracellular nucleic acids from a sample which is or is derived from a body fluid, preferably selected from blood, plasma or serum, wherein for isolation extracellular nucleic acids are bound to a solid phase carrying anion exchange groups, wherein said method comprises the following steps:
Dependencies are inferred from the claim text.